MA
51
-2
AVB
30
-2
UHS
60
-2
AXP
71
-3
XRAY
28
-3
MDLZ
22
-2
MRK
56
-4
IR
69
-3
T
27
-2
O
35
-7
EQR
39
-3
AFL
42
-6
LEG
58
-4
HAL
47
-6
LB
22
-7
FLR
40
-2
EOG
32
-14
JBHT
63
-2
ICE
60
-4
ZTS
19
2
MA
51
-2
AVB
30
-2
UHS
60
-2
AXP
71
-3
XRAY
28
-3
MDLZ
22
-2
MRK
56
-4
IR
69
-3
T
27
-2
O
35
-7
EQR
39
-3
AFL
42
-6
LEG
58
-4
HAL
47
-6
LB
22
-7
FLR
40
-2
EOG
32
-14
JBHT
63
-2
ICE
60
-4
ZTS
19
2
Financhill
Back

Western Asset High Income Fund II Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
27

HIX
Western Asset High Income Fund II

Last Price:
$4.10
Seasonality Move:
-3.79%
Sell
36

MNPR
Monopar Therapeutics, Inc.

Last Price:
$72.27
Seasonality Move:
36.18%
Sell
27
Western Asset High Income Fund II (HIX) is a Sell

Is Western Asset High Income Fund II a Buy, Sell or Hold?

  • The current Western Asset High Income Fund II [HIX] share price is $4.11. The Score for HIX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • HIX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $71.47. The Score for MNPR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HIX Stock Price Chart

What is Western Asset High Income Fund II's stock price today?

  • The Western Asset High Income Fund II share price today is $4.11
    The current trend is moderately bearish and HIX is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $71.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.

HIX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 38.31 Sell
Chaikin Money Flow: 594179 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.27 Sell
Relative Strength Index (14 RSI): 37.77 Sell
Chaikin Money Flow: -61015 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (75.54 - 86.44) Sell
Bollinger Bands (100): (44.45 - 88.87) Buy

HIX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.14 Sell
20-day SMA: 4.16 Sell
50-day SMA: 4.23 Sell
200-day SMA: 4.23 Sell
8-day EMA: 4.13 Sell
20-day EMA: 4.14 Sell
50-day EMA: 3.71 Buy
200-day EMA: 1.76 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 76.09 Sell
20-day SMA: 80.86 Sell
50-day SMA: 83.38 Sell
200-day SMA: 51.78 Buy
8-day EMA: 75.84 Sell
20-day EMA: 78.85 Sell
50-day EMA: 77.98 Sell
200-day EMA: 56.35 Buy

Western Asset High Income Fund II Earnings Growth & HIX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Western Asset High Income Fund II Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):